The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

K Riazi, H Azhari, JH Charette… - The lancet …, 2022 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to …

Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons

MH Le, DM Le, TC Baez, Y Wu, T Ito, EY Lee… - Journal of …, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …

Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015

PK Song, QQ Man, LI Hong, SJ Pang, SS Jia… - Biomedical and …, 2019 - Elsevier
Objective To investigate the trends of lipid profiles and dyslipidemia among Chinese adults
from 2002 to 2015. Methods Data were collected from three nationally representative cross …

Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis

S Lu, Q Xie, M Kuang, C Hu, X Li, H Yang… - Journal of Translational …, 2023 - Springer
Background Body mass index (BMI) and lipid parameters are the most commonly used
anthropometric parameters and biomarkers for assessing nonalcoholic fatty liver disease …

The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and chronic obstructive pulmonary disease: the …

R Wu, H Gong - Frontiers in Nutrition, 2024 - frontiersin.org
Background Numerous studies have indicated a potential correlation between COPD, lipid
metabolism, and dietary inflammation. However, the exact mechanisms by which dietary …

Dyslipidemia in nonalcoholic fatty liver disease

AJ Amor, V Perea - Current Opinion in Endocrinology, Diabetes …, 2019 - journals.lww.com
In addition to being the main determinant of dyslipidemia, disturbances in triglyceride-rich
lipoproteins are thought to be the key factor of increased CVD risk in NAFLD. Treatments …

Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: A pilot double-blind, placebo …

F Naeini, Z Namkhah, H Tutunchi… - European Journal of …, 2022 - journals.lww.com
Objective Although several experimental models have suggested promising
pharmacological effects of naringenin in the management of obesity and its related …

[HTML][HTML] Whole-fat or reduced-fat dairy product intake, adiposity, and cardiometabolic health in children: a systematic review

TA O'Sullivan, KA Schmidt, M Kratz - Advances in Nutrition, 2020 - Elsevier
Dietary guidelines commonly recommend that children aged> 2 y consume reduced-fat
dairy products rather than regular-or whole-fat dairy. In adults, most studies have not found …

Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population

S Lu, M Kuang, J Yue, C Hu, G Sheng… - Lipids in health and …, 2022 - Springer
Background Traditional and non-traditional (TNNT) lipid indicators are known to be closely
related to nonalcoholic fatty liver disease (NAFLD). This study's objective was to compare …

Association of non‐high‐density lipoprotein cholesterol/high‐density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes …

M Liu, J Pei, C Zeng, Y Xin, Y Zhang… - Diabetes, Obesity …, 2025 - Wiley Online Library
Aim To explore the association between the non‐high‐density lipoprotein cholesterol (HDL‐
C)/HDL‐C ratio (NHHR) and the risk of major adverse cardiovascular events (MACEs) and …